Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1984 | The ß-globin gene family in murine erythroleukemia cells resides within two chromatin domains differing in higher order structure | Smith, R. D.; Yu, J.; Annunziato, A.; Seale, R. D. | Biochemistry 23, 2970-2976 | | | |
1988 | The effect of deoxyadenosine plus deoxycoformycin on replicative and repair DNA synthesis in human lymphoblasts and isolated nuclei | Matsumoto, S.; Yu, J.; Yu, A. L | J. Biol. Chem 263, 7153-7158 | | | |
2012 | The essential role of IGF-1R/PI3K/Akt/mTOR pathway in the maintenance and survival of breast cancer stem-like cells | Chang, WW; Yu, J.; Lai, A. C.; Fu, CH; Yu, JC; Yu, AL. | Clinical cancer research | | | |
2002 | The histone deacetylase inhibitor AN-9 has selective toxicity to drug-resistant primary leukemia and cancer cell lines | Batova, A.; Shao, L. E.; Diccianni, M. B.; Yu, A. L.; Tanaka, T.; Rephaeli, A.; Nudelman, A.; Yu, J. | Blood 100, 3319-3324 | | | |
2001 | Thioredoxin expression in primary childhood T-cell acute lymphoblastic leukemia and its therapeutic implications | Shao, L. E.; Diccianni, M. B.; Tanaka, T.; Yu, A. L.; Bessent, E.; Pullen, J.; Yu, J. | Cancer Res 61, 7333-7338 | | | |
2002 | Thioredoxin-related regulation of NO and NOS activities | Shao, LE; Tanaka, T; Gribi, R; Yu, J. | Ann. N.Y. Acad. Sci 962, 140-150 | | | |
1983 | Transcribed chromatin exhibits an altered nucleosomal spacing | Smith, R. D.; Seale, R. L.; Yu, J. | Proc. Natl. Acad. Sci. USA 80, 5505-5509 | | | |
2000 | Truncated activin type II receptor inhibits erythroid differentiation in K562 cells | Liu, F.; Shao, L. E.; Yu, J. | J. Cell Biochem 78, 24-33 | | | |
2009 | Unique de-repression of astrocyte-associated GFAP gene during cell fate specification through Sin3A repressor complex. | Chang, W. W; Yang, B. C; Yang, K. J; Chen, Y. Y; Yu, J. | | | | |
2009 | Unique Features of De-repression of GFAP during Cell Fate Specification of Human NTera-2 Cells toward Astrocyte Lineage | Cheng, P. Y; Lin, Y. P; Chen, Y. L; Wang, Y. T; Kao, C. F; Chen, Y. J; Yu, J. | | | | |
2000 | Universal inactivation of both p16 and p15 but not downstream components is an essential event in pathogenesis of T-cell acute lymphoblastic leukemia | Omura-Minamisawa, M.; Diccianni, M. B.; Batova, A.; Chang, R. C.; Bridgeman, L.; Yu, J.; Pullen, J.; Bowman, W. P.; Yu, A. L. | CLINICAL CANCER RESEARCH 6, 1219-1228 | | | |
1999 | Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro | Batova, A.; Diccianni, M. B.; Yu, J.; Carrera, C. J.; Bridgeman, L. J.; Kung, F. H.; Pullen, J.; Amylon, M. D.; Yu, A. L. | Cancer Research 59, 1492-1497 | | | |